Hormone replacement therapy (HRT) is most likely right for you if you’re under 60, within 10 years of menopause, and dealing with symptoms that interfere with your daily life. That’s the short answer, but the full picture depends on your specific symptoms, your medical history, and which type of hormone therapy fits your situation. Here’s what you need to weigh.
What HRT Actually Treats
HRT is FDA-approved to treat a specific set of menopause symptoms: hot flashes, night sweats, vaginal dryness, and pain during sex. It’s also approved to help prevent osteoporosis. If your main complaints fall outside this list, such as mood changes, brain fog, or joint pain, HRT may still help indirectly (poor sleep from night sweats causes a lot of downstream problems), but the strongest evidence is for those core symptoms.
The severity of your symptoms matters. HRT is considered a first-line treatment for moderate to severe hot flashes and night sweats. If you’re having a few mild hot flashes a week and they don’t bother you much, lifestyle changes or waiting it out may be enough. But if you’re soaking through sheets at night, unable to function at work, or avoiding intimacy because of vaginal pain, those are exactly the situations HRT was designed for.
The Timing Window
When you start HRT matters as much as whether you start it. Research consistently shows that the best benefit-to-risk ratio comes from beginning therapy within six years of menopause and before age 60. Women who start in this window see the greatest reductions in fracture risk and overall mortality, and they avoid the elevated cardiovascular risks that show up when older women begin HRT for the first time. Starting HRT in your 50s and continuing for five years or more substantially increases quality-adjusted life years compared to no therapy at all.
If you’re well past 60 or more than a decade out from your last period, initiating systemic HRT carries more risk and fewer benefits. That doesn’t mean hormones are off the table entirely (low-dose vaginal estrogen is still safe and effective for urinary and vaginal symptoms at any age), but the calculus for whole-body therapy shifts.
Who Should Avoid It
Certain medical conditions make systemic HRT a poor fit. If you have a personal history of breast cancer, blood clots, stroke, heart attack, or active liver disease, standard hormone therapy is generally not recommended. These are situations where the risks clearly outweigh the benefits.
A family history of breast cancer, on the other hand, doesn’t automatically rule you out. The actual increase in breast cancer risk from combined estrogen-plus-progestogen therapy is modest: about a 10% higher rate compared to women who never use hormones. In practical terms, that translates to roughly a 4.5% cumulative risk of breast cancer before age 55, compared to 4.1% for nonusers. Estrogen-only therapy (for women who’ve had a hysterectomy) actually showed a 14% reduction in breast cancer incidence. These numbers are worth discussing with your doctor in the context of your personal risk factors.
Systemic vs. Local Therapy
Not all HRT is the same, and the type you need depends on what’s bothering you. Systemic hormone therapy, which comes as pills, patches, gels, sprays, or rings, delivers estrogen throughout your entire body. It’s the most effective treatment for hot flashes, night sweats, and bone loss prevention. If your symptoms are widespread, systemic therapy is typically the right choice.
If your only complaints are vaginal dryness, painful sex, or urinary symptoms like frequent infections or urgency, low-dose vaginal estrogen is usually the better option. It comes as a cream, tablet, or ring and delivers a much smaller amount of estrogen that stays mostly local. Because so little is absorbed into the bloodstream, vaginal estrogen carries far fewer systemic risks and can be used by many women who aren’t candidates for whole-body therapy.
How Delivery Method Affects Risk
Even within systemic therapy, how you take estrogen changes your risk profile significantly. Oral estrogen pills pass through the liver before reaching the rest of your body, and this “first pass” effect increases the risk of blood clots. Compared to patches or gels, oral estrogen carries a 63% higher risk of a first blood clot and a possibly elevated stroke risk as well.
Transdermal options (patches, gels, sprays) bypass the liver and deliver estrogen directly into the bloodstream through the skin. For women who are overweight, have a history of migraines, or have any reason to be cautious about clotting risk, transdermal estrogen is the safer route. If you and your doctor decide systemic HRT makes sense, asking specifically about a patch or gel is worth the conversation.
Body-Identical vs. Compounded Hormones
You may have heard the term “bioidentical hormones” marketed as a natural or safer alternative. There’s an important distinction here. FDA-approved body-identical hormones, sometimes called regulated bioidentical hormones, are chemically identical to the hormones your body produces and are manufactured under strict quality controls. These are widely available by prescription and are a standard, well-studied option.
Custom-compounded bioidentical hormones are a different story. These are mixed by compounding pharmacies and are not subject to the same safety testing, dosing consistency checks, or quality controls as regulated products. They may contain inconsistent amounts of hormones from batch to batch, undesirable additives, or even hormones not approved for use in women. They also don’t carry the safety warnings required on all prescribed HRT. The claims around compounded hormones often outpace the evidence, and the lack of standardization can actually increase risks like blood clots and endometrial cancer. If someone is specifically recommending compounded bioidentical hormones, ask why an FDA-approved version wouldn’t work instead.
Non-Hormonal Alternatives
If HRT isn’t safe for you, or if you simply prefer not to take hormones, there’s now an FDA-approved non-hormonal option specifically for hot flashes. Veozah (fezolinetant) works by blocking a receptor in the brain involved in temperature regulation. It’s taken as a daily pill and was shown to reduce moderate to severe hot flashes in two phase 3 clinical trials. It won’t help with vaginal dryness or bone loss the way estrogen does, but for women whose main problem is hot flashes and who can’t take hormones due to a history of clots, stroke, or breast cancer, it fills an important gap.
You Probably Don’t Need a Blood Test First
Many women assume they need hormone level testing before starting HRT. In most cases, you don’t. Menopause is defined as 12 consecutive months without a period when no other cause explains the change. For women in their 40s and 50s experiencing classic symptoms, blood tests for hormones like FSH fluctuate so much from day to day that they can’t reliably diagnose menopause, predict when it will happen, or guide treatment decisions. The American Academy of Family Physicians specifically recommends against routine FSH testing in women in their 40s with irregular periods. Your symptoms and medical history are more useful than a lab number.
Putting It Together
HRT tends to be a good fit if you’re dealing with moderate to severe hot flashes, night sweats, or vaginal symptoms; you’re under 60 or within a few years of menopause; and you don’t have a history of breast cancer, blood clots, stroke, or liver disease. The fracture prevention benefits are substantial, with studies showing a 27% to 40% reduction in hip and other fractures, making bone health an additional consideration if you’re at risk for osteoporosis.
The decision isn’t one-size-fits-all. A woman with a uterus will need progestogen alongside estrogen to protect against endometrial overgrowth, while a woman who’s had a hysterectomy can take estrogen alone, which carries a lower breast cancer risk. Someone with clotting concerns might do well on a patch but should avoid pills. Someone with only vaginal symptoms might need nothing more than a low-dose vaginal cream. The right version of HRT is as important as the decision to use it at all.